This past week has been busy with lots of big announcements in the industry. Here are some of the top stories which are creating buzz in the regulatory world: The FDA approved Takeda/Ariad’s ALUNBRIG for the treatment of non-small cell lung cancer. This is great news for Takeda who recently completed their purchase of Ariad. ALUNBRIG is an orphan[…]